IVZ
55
6
MS
72
-4
WYNN
41
4
BBY
41
-5
AVY
57
6
PFE
26
3
PDCO
46
8
FMC
40
6
SIG
55
5
UHS
56
2
ED
52
4
YUM
49
2
MDLZ
38
2
CHD
48
-6
LOW
59
9
DOW
46
2
BSX
64
-3
AON
56
2
VRTX
52
5
INTU
53
-3
IVZ
55
6
MS
72
-4
WYNN
41
4
BBY
41
-5
AVY
57
6
PFE
26
3
PDCO
46
8
FMC
40
6
SIG
55
5
UHS
56
2
ED
52
4
YUM
49
2
MDLZ
38
2
CHD
48
-6
LOW
59
9
DOW
46
2
BSX
64
-3
AON
56
2
VRTX
52
5
INTU
53
-3
Financhill
Back

Replimune Group Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47

REPL
Replimune Group

Last Price:
14.40
Seasonality Move:
-14.22%

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.

Replimune Group Price Quote

$14.40
+1.14 (+8.6%)
(Updated: November 26, 2024 at 5:55 PM ET)

Replimune Group Key Stats

Sell
47
Replimune Group (REPL) is a Sell
Day range:
$12.71 - $15.12
52-week range:
$4.92 - $17.00
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.38%
Volume:
2.9M
Avg. volume:
775.2K
1-year change:
27.62%
Market cap:
$907.2M
Revenue:
$0
EPS:
$-3.05

How Much Does Replimune Group Make?

Data Unavailable

Is Replimune Group Growing As A Company?

Data Unavailable

Replimune Group Stock Price Performance

  • Did Replimune Group Stock Go Up Last Month?
    Replimune Group share price went up by 13.04% last month
  • Did REPL's Share Price Rise Over The Last Year?
    REPL share price rose by 27.62% over the past 1 year

What Is Replimune Group 52-Week High & Low?

Replimune Group Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Replimune Group?

  • How Much Debt Does Replimune Group Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Replimune Group Have?
    Cash and short term investments quarterly total is $432.1M
  • What Is Replimune Group’s Book Value Per Share?
    Book value per share is 5.58

Is Replimune Group Cash Flow Positive?

  • What Is REPL Cash Flow From Operations?
    Cash flow from operations (TTM) is -$181.1M
  • What Is Replimune Group’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $111.3M
  • What Is Replimune Group’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $107.4M

Replimune Group Return On Invested Capital

Data Unavailable

Replimune Group Earnings Date & Stock Price

Replimune Group Competitors

  • Who Are Replimune Group's Competitors?
    Below is a list of companies who compete with Replimune Group or are related in some way:
    • Bristol-Myers Squibb Co (BMY)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Nuvalent Inc (NUVL)
    • Pfizer Inc (PFE)
    • Palatin Technologies Inc (PTN)

Replimune Group Dividend Yield

Replimune Group Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 7.69%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 16.50
Upside from Last Price: 24.43%

Major Shareholders

  • How many REPL shares are owned by institutional investors?
    116M REPL shares are owned by institutional investors
  • How many REPL shares are owned by insiders?
    5.2M REPL shares are owned by insiders